McAllister, K. A., Baldwin, M. A., Thukkani, A. K., Gallione, C. J., Berg, J. N., Porteous, M. E., … Marchuk, D. A. (1995). Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet, 4(10), 1983–1985. https://doi.org/10.1093/hmg/4.10.1983

McAllister, K. A., M. A. Baldwin, A. K. Thukkani, C. J. Gallione, J. N. Berg, M. E. Porteous, A. E. Guttmacher, and D. A. Marchuk. “Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function.” Hum Mol Genet 4, no. 10 (October 1995): 1983–85. https://doi.org/10.1093/hmg/4.10.1983.

McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, et al. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet. 1995 Oct;4(10):1983–5.

McAllister, K. A., et al. “Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function.” Hum Mol Genet, vol. 4, no. 10, Oct. 1995, pp. 1983–85. Pubmed, doi:10.1093/hmg/4.10.1983.

McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, Marchuk DA. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet. 1995 Oct;4(10):1983–1985.